Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28196
Title: The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer.
Austin Authors: Granger, Catherine L ;Parry, Selina M;Denehy, Linda
Affiliation: Institute for Breathing and Sleep
Department of Physiotherapy, The University of Melbourne, Level 7 Alan Gilbert Building, 161 Barry Street, Melbourne, Victoria, 3010, Australia
Department of Physiotherapy, Royal Melbourne Hospital, Grattan Street, Melbourne, Victoria, 3010, Australia
Issue Date: Nov-2015
Date: 2015-03-26
Publication information: Supportive care in cancer 2015; 23(11): 3211-3218
Abstract: Physical activity (PA) is an important outcome in lung cancer; however, there is lack of consensus as to the best method for assessment. The Physical Activity Scale for the Elderly (PASE) is a commonly used questionnaire. The aim of this study was to assess the clinimetric properties of the PASE in lung cancer, specifically validity, predictive utility and clinical applicability (floor/ceiling effects, responsiveness and minimal important difference [MID]). This is a prospective observational study. Sixty-nine participants (62 % male, median [IQR] age 68 years [61-74]) with lung cancer completed the PASE at diagnosis at 2, 4 and 6 months. Additional measures included movement sensors (steps/day), physical function, health-related quality of life, functional capacity (6-min walk distance [6MWD]), and muscle strength. Spearman's rank correlation coefficient was used to assess relationships. Linear regression analyses were conducted to determine predictive utility of the PASE for health status at 6 months. Responsiveness (effect size) and MID (distribution-based estimation) were calculated. The PASE was administered on 176 occasions. The PASE had moderate convergent validity with movement sensors (rho = 0.50 [95 %CI = 0.29-0.66], p < 0.005) and discriminated between participants classed as sedentary/insufficient/sufficient according to PA guidelines (p < 0.005). The PASE had fair-moderate construct validity with measures of physical function (rho = 0.57 [95 %CI = 0.46-0.66], p < 0.005), 6MWD (rho = 0.40 [95 %CI = 0.23-0.55], p < 0.005), and strength (rho = 0.37 [95 %CI = 0.18-0.54], p < 0.005). The PASE (at diagnosis) exhibited predictive utility for physical function (Bcoef = 0.35, p = 0.008) and quality of life (Bcoef = 0.35, p = 0.023) at 6 months. A small floor effect was observed (3 %); however, there was no ceiling effect. There was a small responsiveness to change (effect size = 0.23) and MID between 17 and 25 points. The PASE is a valid measure of self-reported PA in lung cancer.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28196
DOI: 10.1007/s00520-015-2707-8
ORCID: 0000-0001-6169-370X
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
PubMed URL: 25808104
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/25808104/
Type: Journal Article
Subjects: Clinimetric properties
Lung cancer
Physical activity
Questionnaires
Self-report
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Apr 15, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.